Linezolid treatment for gram-positive infections: a retrospective comparison with teicoplanin (Q34989916)

5 August 2017

title

Linezolid treatment for gram-positive infections: a retrospective comparison with teicoplanin (English)

1 reference

5 August 2017

main subject

gram-positive bacteria

0 references

1 reference

Tascini C

1

1 reference

5 August 2017

Gemignani G

2

1 reference

5 August 2017

Doria R

3

1 reference

5 August 2017

Biancofiore G

4

1 reference

5 August 2017

Urbani L

5

1 reference

5 August 2017

Mosca C

6

1 reference

5 August 2017

Malacarne P

7

1 reference

5 August 2017

Papineschi F

8

1 reference

5 August 2017

Passaglia C

9

1 reference

5 August 2017

Dal Canto L

10

1 reference

5 August 2017

Procaccini M

11

1 reference

5 August 2017

Furneri G

12

1 reference

5 August 2017

Didoni G

13

1 reference

5 August 2017

Filipponi F

14

1 reference

5 August 2017

Menichetti F

15

1 reference

5 August 2017

publication date

1 June 2009

1 reference

5 August 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Journal of Chemotherapy

1 reference

5 August 2017

volume

21

1 reference

5 August 2017

issue

3

1 reference

5 August 2017

page(s)

311-316

1 reference

Linezolid: the first oxazolidinone antimicrobial

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.311

A review of linezolid: the first oxazolidinone antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.311

Quinupristin-dalfopristin and linezolid: evidence and opinion

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.311

Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.311

Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.311

Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.311

Healthcare-associated pneumonia in adults: management principles to improve outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.311

Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.311

An economic evaluation of a European cohort from a multinational trial of linezolid versus teicoplanin in serious Gram-positive bacterial infections: the importance of treatment setting in evaluating treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.311

Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.3.311

10.1179/JOC.2009.21.3.311

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference